Forma Therapeutics, Inc.
Clinical trials sponsored by Forma Therapeutics, Inc., explained in plain language.
-
New pill hopes to boost blood in bone marrow disease
Disease control TerminatedThis study tested a drug called etavopivat in 17 adults with a low-risk form of myelodysplastic syndromes (MDS) who had anemia. The goal was to see if the drug could safely raise hemoglobin levels or reduce the need for blood transfusions. The trial was stopped early, so results …
Phase: PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
Fatty liver drug trial halted early: what we know
Disease control TerminatedThis early-stage study tested an experimental drug called FT-4101 in 14 overweight or obese adults with NASH, a serious fatty liver disease. The main goals were to check safety and see if the drug could reduce liver fat. The study was stopped early, so results are limited and no …
Phase: PHASE1, PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 12:01 UTC